| Financial Year |
March 31 2023 |
| Monetary Funds |
33,296,993.08 |
| Held-for-trading Financial Assets |
5,265,526.28 |
| Notes Receivable |
209,412.21 |
| Accounts Receivable |
37,629,012.26 |
| Advances to Suppliers |
3,465,264.43 |
| Other Receivables |
24,015,918.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
24,785,669.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,442,071.49 |
| Total Current Assets |
135,109,867.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
179,509,033.30 |
| Under-construction Projects |
250,176.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,192,736.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,667,089.23 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
1,174,499.46 |
| Sub-Total of Non-Current Assets |
310,232,039.90 |
| Total Assets |
445,341,907.43 |
| Short-Term Loans |
79,592,893.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,718,927.63 |
| Accounts Payable |
43,306,298.40 |
| Accounts Received In Advance |
437,297.20 |
| Employee Compensation Payable |
4,635,047.69 |
| Taxes Payable |
3,135,943.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,811,348.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,758,939.70 |
| Other Current Liabilities |
301,239.84 |
| Sub-Total of Current Liabilities |
146,488,112.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,245,764.62 |
| Deferred Income Tax Liabilities |
4,172,031.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,103,386.89 |
| Total Liabilities |
179,591,499.62 |
| Paid-In Capital(Or Share Stock) |
209,185,200.00 |
| Capital Surplus |
470,038,734.36 |
| Surplus Reserve |
54,339,604.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-462,702,652.45 |
| Minority Stockholder's Interest |
-5,029,964.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
270,780,372.67 |
| Owner's Equity（Stockholder's Equity） |
265,750,407.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
445,341,907.43 |
